logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Gábor Liposits

Kantonsspital St. Gallen
H指数:15
被引数:1,259

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prediction models for overall survival and all-cause mortality risk in older adults with cancer: a systematic review

老年癌症患者总生存期和全因死亡风险预测模型：一项系统综述

The Lancet Healthy Longevity
IF0
2026-03-210
OAAI
Pauline Duquenne; Gabor Liposits; Cassandra O Vonnes; Erna Navarrete; Adolfo Gonzalez Serrano; Florence Canoui-Poitrine; Joana Marinho; Baran Akagündüz; Kristen R Haase; Haydee C Verduzco-Aguirre; Juan Li; Colm Mac Eochagáin; Enrique Soto-Perez-de-Celis; Ana Patricia Ayala; Joosje C Baltussen; Kavita Kantilal; Kumud Kantilal; Chan Wing-Lok; Andrea Perez de Acha; Shelby Meckstroth
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

ESMO-ESTRO关于将放射治疗与CDK4/6、HER2、PARP或mTOR抑制剂联合应用的安全性共识声明

Radiotherapy and Oncology
IF5.3
2025-12-110
OAAI
Evert S.M. van Aken; Ajeet Kumar Gandhi; Sean M. O’Cathail; Gerben Borst; Jorge Barriuso; Emmanouil Fokas; Luis Castelo-Branco; Anne Hansen Ree; Evandro de Azambuja; Stephanie Kroeze; Ilaria Colombo; Antonin Levy; Carmen Criscitiello; Maximilian Niyazi; Nadia Harbeck; Ewa Szutowicz; Gabor Liposits; Marcel Verheij; Isabelle Ray-Coquard; Paolo Tarantino
Representation of geriatric oncology in cancer care guidelines in Europe: a scoping review by the International Society of Geriatric Oncology (SIOG)

欧洲癌症护理指南中老年肿瘤学的呈现：国际老年肿瘤学会（SIOG）的范畴综述

ESMO OPEN
IF8.3
2025-05-010
PRE
Pinker, I.; Lafont, C.; Liposits, G.; Vidra, R.; Cunquero-Tomas, A. J.; Korobeinikova, E.; Neuendorff, N. R.; Slavova-Boneva, V.; Baltussen, J.; Chovanec, M.; Coutinho, F.; Dubianski, R.; Janzic, U.; Kenis, C.; Kukec, I.; Kuronya, Z.; Lehtomaki, K.; Eochagain, C. M.; Osterlund, E.; Osterlund, P.; Pattwell, M.; Rejlekova, K.; Sharma, T.; Battisti, M. L.; Pilleron, S.
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer

两项3期研究的合并安全性分析，这些研究调查了转移性结直肠癌患者的氟尿苷/替匹拉西加贝伐单抗

FRONTIERS IN ONCOLOGY
IF3.3
2025-01-161
OAAI
Taieb, Julien; Fakih, Marwan; Liposits, Gabor; Prager, Gerald W.; Van Cutsem, Eric; Ciardiello, Fortunato; Amellal, Nadia; Calleja, Elizabeth; Liu, Mei; Roby, Lucas; Tabernero, Josep; Andre, Thierry
Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer

阳光的通俗易懂的总结: 三氟尿苷/替匹拉西和贝伐单抗治疗难治性转移性结直肠癌

FUTURE ONCOLOGY
IF2.6
2024-07-020
OAAI
Prager, Gerald W.; Taieb, Julien; Fakih, Marwan; Ciardiello, Fortunato; Cutsem, Eric Van; Elez, Elena; Wyrwicz, Lucjan; Stroyakovskiy, Daniil; Liposits, Gabor; Bondarenko, Igor; Modest, Dominik P.; Amellal, Nadia; Tabernero, Josep
The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-studye

BRAFV600E突变对易受伤害的老年转移性结直肠癌患者的生存和治疗效果的影响-随机NORDIC9-studye的事后探索性分析

JOURNAL OF GERIATRIC ONCOLOGY
IF2.7
2024-03-010
OA
Liposits, Gabor; Winther, Stine B.; Ryg, Jesper; Skuladottir, Halla; Moller, Soren; Hofsli, Eva; Shah, Carl -Henrik; Poulsen, Laurids Ostergaard; Berglund, Ake; Qvortrup, Camilla; Osterlund, Pia; Glimelius, Bengt; Sorbye, Halfdan; Pfeiffer, Per
Effect of KRASG12 mutations on overall survival in patients with refractory metastatic colorectal cancer: A post-hoc analysis of the phase III SUNLIGHT trial

KRASG12突变对难治性转移性结直肠癌患者总生存期的影响: SUNLIGHT III期试验的事后分析

ANNALS OF ONCOLOGY
IF65.4
2023-10-011
PRE
Tabernero, J.; Prager, G.; Fakih, M.; Ciardiello, F.; Van Cutsem, E.; Elez Fernandez, M. E.; Cruz, F. J. S. M.; Wyrwicz, L. S.; Stroyakovskiy, D.; Papai, Z.; Martinelli, E.; Salvatore, L.; Poureau, P. G.; Liposits, G.; Cremolini, C.; Modest, D. P.; Causse-Amellal, N.; Roby, L.; Skanji, D.; Taieb, J.
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

在不可切除的胰腺癌 (DPCG-01) 的脆弱患者中，全剂量吉西他滨与减少剂量吉西他滨和nab紫杉醇的随机II期研究

BMC CANCER
IF3.4
2023-06-161
OAAI
Rasmussen, Louise Skau; Winther, Stine B.; Chen, Inna M.; Weber, Britta; Ventzel, Lise; Liposits, Gabor; Johansen, Julia Sidenius; Detlefsen, Soenke; Egendal, Ida; Shim, Susy; Christensen, Signe; Pfeiffer, Per; Ladekarl, Morten

研究方向

暂未获取到该数据
P
Per Pfeiffer
H 指数:60论文数:548被引数:2.1万
B
Bengt Glimelius
H 指数:115论文数:1,002被引数:7.4万
S
Sören Möller
H 指数:42论文数:546被引数:8,874
P
Pia Österlund
H 指数:36论文数:216被引数:1.1万
S
Stine Brændegaard Winther
H 指数:10论文数:41被引数:523
J
Jesper Ryg
H 指数:34论文数:310被引数:5,885
H
Halfdan Sørbye
H 指数:49论文数:249被引数:1.3万
K
Kah Poh Loh
H 指数:43论文数:375被引数:7,010
E
Enrique Soto‐Pérez‐de‐Celis
H 指数:40论文数:365被引数:7,314
N
Nicolò Matteo Luca Battisti
H 指数:28论文数:166被引数:2,802